147 related articles for article (PubMed ID: 9261360)
1. Isolation and characterization of human papillomavirus type 6-specific T cells infiltrating genital warts.
Hong K; Greer CE; Ketter N; Van Nest G; Paliard X
J Virol; 1997 Sep; 71(9):6427-32. PubMed ID: 9261360
[TBL] [Abstract][Full Text] [Related]
2. The role of the immune system in anogenital human papillomavirus.
Frazer IH
Australas J Dermatol; 1998 Nov; 39 Suppl 1():S5-7. PubMed ID: 9842093
[TBL] [Abstract][Full Text] [Related]
3. Prospective study on the development of antibodies against human papillomavirus type 6 among patients with condyloma acuminata or new asymptomatic infection.
Wikström A; van Doornum GJ; Kirnbauer R; Quint WG; Dillner J
J Med Virol; 1995 Aug; 46(4):368-74. PubMed ID: 7595415
[TBL] [Abstract][Full Text] [Related]
4. Induction of human papillomavirus-specific CD4(+) and CD8(+) lymphocytes by E7-pulsed autologous dendritic cells in patients with human papillomavirus type 16- and 18-positive cervical cancer.
Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Zhan D; Pecorelli S; Parham GP; Cannon MJ
J Virol; 1999 Jul; 73(7):5402-10. PubMed ID: 10364287
[TBL] [Abstract][Full Text] [Related]
5. Single-cell cytokine analysis allows detection of cervical T-cell responses against human papillomavirus type 16 L1 in women infected with genital HPV.
Passmore JA; Burch VC; Shephard EG; Marais DJ; Allan B; Kay P; Rose RC; Williamson AL
J Med Virol; 2002 Jun; 67(2):234-40. PubMed ID: 11992584
[TBL] [Abstract][Full Text] [Related]
6. Frequent display of human papillomavirus type 16 E6-specific memory t-Helper cells in the healthy population as witness of previous viral encounter.
Welters MJ; de Jong A; van den Eeden SJ; van der Hulst JM; Kwappenberg KM; Hassane S; Franken KL; Drijfhout JW; Fleuren GJ; Kenter G; Melief CJ; Offringa R; van der Burg SH
Cancer Res; 2003 Feb; 63(3):636-41. PubMed ID: 12566307
[TBL] [Abstract][Full Text] [Related]
7. Local and systemic human papillomavirus type 6b-specific cellular immune responses in patients with recurrent genital warts.
Blanchet JS; Sonnex C; Gough GW; Warren AP
Viral Immunol; 2007; 20(1):44-55. PubMed ID: 17425420
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus type 16 E7 peptide-directed CD8+ T cells from patients with cervical cancer are cross-reactive with the coronavirus NS2 protein.
Nilges K; Höhn H; Pilch H; Neukirch C; Freitag K; Talbot PJ; Maeurer MJ
J Virol; 2003 May; 77(9):5464-74. PubMed ID: 12692247
[TBL] [Abstract][Full Text] [Related]
9. The immunology of genital human papilloma virus infection.
Stanley M
Eur J Dermatol; 1998; 8(7 Suppl):8-12; discussion 20-2. PubMed ID: 10387957
[TBL] [Abstract][Full Text] [Related]
10. Mapping of cytotoxic T lymphocytes epitopes in E7 antigen of human papillomavirus type 11.
Xu Y; Zhu KJ; Chen XZ; Zhao KJ; Lu ZM; Cheng H
Arch Dermatol Res; 2008 Jun; 300(5):235-42. PubMed ID: 18299861
[TBL] [Abstract][Full Text] [Related]
11. T cell epitopes in human papilloma virus proteins.
Sadovnikova E; Stauss HJ
Behring Inst Mitt; 1994 Jul; (94):87-93. PubMed ID: 7528003
[TBL] [Abstract][Full Text] [Related]
12. Immunological events in regressing genital warts.
Coleman N; Birley HD; Renton AM; Hanna NF; Ryait BK; Byrne M; Taylor-Robinson D; Stanley MA
Am J Clin Pathol; 1994 Dec; 102(6):768-74. PubMed ID: 7801889
[TBL] [Abstract][Full Text] [Related]
13. Identification of seroreactive epitopes of human papillomavirus type 18 E7 protein by synthetic peptides.
Krchnák V; Pistĕk T; Vágner J; Suchánková A; Kañka J; Ritterová L; Vonka V
Acta Virol; 1993 Oct; 37(5):395-402. PubMed ID: 7514354
[TBL] [Abstract][Full Text] [Related]
14. Spectrum of genital human papillomavirus infection in a female adolescent population.
Jamison JH; Kaplan DW; Hamman R; Eagar R; Beach R; Douglas JM
Sex Transm Dis; 1995; 22(4):236-43. PubMed ID: 7482107
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical, histological, and virological symptoms of HPV in HIV-1 infected men and immunocompetent subjects.
Aynaud O; Piron D; Barrasso R; Poveda JD
Sex Transm Infect; 1998 Feb; 74(1):32-4. PubMed ID: 9634298
[TBL] [Abstract][Full Text] [Related]
16. Immunological responses in women with human papillomavirus type 16 (HPV-16)-associated anogenital intraepithelial neoplasia induced by heterologous prime-boost HPV-16 oncogene vaccination.
Smyth LJ; Van Poelgeest MI; Davidson EJ; Kwappenberg KM; Burt D; Sehr P; Pawlita M; Man S; Hickling JK; Fiander AN; Tristram A; Kitchener HC; Offringa R; Stern PL; Van Der Burg SH
Clin Cancer Res; 2004 May; 10(9):2954-61. PubMed ID: 15131030
[TBL] [Abstract][Full Text] [Related]
17. Established human papillomavirus type 16-expressing tumors are effectively eradicated following vaccination with long peptides.
Zwaveling S; Ferreira Mota SC; Nouta J; Johnson M; Lipford GB; Offringa R; van der Burg SH; Melief CJ
J Immunol; 2002 Jul; 169(1):350-8. PubMed ID: 12077264
[TBL] [Abstract][Full Text] [Related]
18. Clinical presentation and natural course of anogenital warts.
Handsfield HH
Am J Med; 1997 May; 102(5A):16-20. PubMed ID: 9217658
[TBL] [Abstract][Full Text] [Related]
19. Epidemiology of genital human papillomavirus infection.
Koutsky L
Am J Med; 1997 May; 102(5A):3-8. PubMed ID: 9217656
[TBL] [Abstract][Full Text] [Related]
20. Ex vivo analyses of ano-genital wart lymphocytes to study the human papillomavirus immune response.
Heaps A; Hanna N; Stanley M; Goon P
Acta Derm Venereol; 2009; 89(3):303-4. PubMed ID: 19479132
[No Abstract] [Full Text] [Related]
[Next] [New Search]
